Conditional overexpression of human cyclins Bi, DI, and E was accomplished by using a synthetic cDNA expression system based on the Escherichia coli tetracycline repressor. After induction of these cyclins in asynchronous Rat-1 fibroblasts, a decrease in the length of the G, interval was observed for cyclins Dl and E, consistent with an acceleration of the G,/S phase transition. We observed, in addition, a compensatory lengthening of S phase and G2 so that the mean cell cycle length in populations constitutively expressing these cyclins was unchanged relative to those of their uninduced counterparts. We found that expression of cyclin Bi had no effect on cell cycle dynamics, despite elevated levels of cyclin B-associated histone Hi kinase activity. Induction of cyclins Dl and E also accelerated entry into S phase for synchronized cultures emerging from quiescence. However, whereas cyclin E exerted a greater effect than cyclin Dl in asynchronous cycling cells, cyclin Dl conferred a greater effect upon stimulation from quiescence, suggesting a specific role for cyclin Dl in the Go-to-G1 transition. Overexpression of cyclins did not prevent cells from entering into quiescence upon serum starvation, although a slight delay in attainment of quiescence was observed for cells expressing either cyclin Di or cyclin E. These results suggest that cyclins Dl and E are rate-limiting activators of the Gl-to-S phase transition and that cyclin Dl might play a specialized role in facilitating emergence from quiescence.
Cyclins are positive regulators of cell cycle progression, initially identified in early-cleavage embryos of marine invertebrates as proteins that accumulated during interphase and were degraded at mitosis (12) . Cyclins are now known to be positive regulatory subunits of a class of protein kinases termed cyclin-dependent kinases (Cdks). These protein kinases have been shown in a number of diverse eukaryotic systems to be the master regulators of major cell cycle transitions (23, 27, 33, 37) . This has been demonstrated most clearly in the budding yeast Saccharomyces cerevisiae, in which Cdk activities are essential for both the GI-to-S phase transition and the G2to-M phase transition. In this organism, separate classes of cyclins associate with the unique Cdk, Cdc28, to generate successively S-phase-inductive and M-phase-inductive activities (19, 26) . For mammalian cells, a detailed description of the roles of cyclins and Cdks is still emerging. However, it is clear that a higher level of complexity exists than has been found in yeasts. First, rather than utilizing a single Cdk, mammalian cells have been found to have at least five (22, 31, 34, 42) . Second, superimposed on this multiplicity of Cdk catalytic subunits is a growing list of different structural types of cyclins (19, 31, 47) . Although the combinatorial possibilities have not been thoroughly explored, it is already clear that some cyclins can associate with and activate more than one Cdk and conversely some Cdks can associate with and be activated by more than one cyclin (31, 42) .
To date, it has been established that the Cdk Cdc2Hs, when associated with cyclin B and possibly with cyclin A, is responsible for M-phase-inductive activities (27) . Cyclin A, associated with a different Cdk, Cdk2, has been shown to promote S phase (8, 29, 49) , although it is not yet clear whether it is required for S-phase initiation or for progression through S phase. The the targets of afferent cell cycle control signals. To this end, we initially set out to express several candidate human G, cyclin cDNAs constitutively at high levels in a variety of mammalian cell lines. We were unable to recover such stable cell lines, suggesting that chronic high-level cyclin expression might be toxic. We have therefore employed a conditional expression system that allows the recovery of stable transfectant cell lines under conditions in which cyclins are not expressed until dictated by experimental design. In this manner, all effects associated with chronic expression are avoided. We report here the effects on cell cycle progression of conditional ectopic expression of cyclins Dl, E, and Bi. During the course of this work, two other studies in which cyclin E (28) and cyclin Dl (35) were constitutively overexpressed in noncloned fibroblast populations were published. Our study reached similar conclusions.
MATERIALS AND METHODS
Plasmids. The pUHD15-1 neo plasmid contains the tTA transactivator gene as described for pUHD15-1 (9) and, in addition, a neomycin resistance gene. The pUHD10-3 plasmid contains seven repeats of the tet operator linked to a cytomegalovirus minimal promoter (PcMv*-1 [see reference 9] ), upstream from a polylinker convenient for cloning and a simian virus 40 polyadenylation signal. The tetracycline-regulated lacZ expression plasmid pUHG16-3 contains PcMv*-I followed by a 3-galactosidase gene and a globin intron/polyadenylation signal. To construct tet-cyclin E and tet-cyclin DI plasmids, we cloned the SpeI-XbaI fragments of Rc/cyclin E and Rc/cyclin Dl (11) , which contain the full-length cDNAs corresponding to human cyclins E and D1 into the XbaI site of pUHD10-3. To construct the tet-cyclin Bi plasmid, we cloned the full-length cDNA of human cyclin B1 into the BamHI site of pUHD10-3. This full-length cDNA was a BglII fragment from the plasmid HC4 which was isolated in a screen to complement a GI cyclin deficiency in Saccharomyces cerevisiae (17) . The Tk-hygromycin plasmid contains the hygromycin resistance gene under control of the thymidine kinase (Tk) promoter. It was constructed and kindly provided by N. Quintrell and M. Bishop, University of California, San Francisco.
Cell lines, transfection, and selection procedure. Rat-I cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal calf serum (FCS), 2 mM glutamine, 100 U of penicillin per ml, and 100 jig of streptomycin per ml. Plasmid pUHD15-1 neo linearized with ScaI (10 jig) was transfected into a 60-mm-diameter plate of Rat-1 cells by using the calcium phosphate precipitation technique. Clones were selected in the presence of 400 jig of active G418 (Geneticin; GIBCO) per ml and were tested for their ability to induce expression from the tetracycline promoter in transient-transfection assays. Plasmid pUHG16-3 or tet-cyclin E (10 jig) was transfected into 60-mmdiameter plates in the presence or absence of 1 jLg of tetracycline (Sigma) per ml. The cells were extracted 48 h later, and proteins were analyzed by sodium dodecyl sulfate (SDS)polyacrylamide gel electrophoresis and then by immunoblotting with anti-cyclin E polyclonal antibodies (7) or anti P-galactosidase monoclonal antibodies (Promega). Clone R12 was found to induce expression from both plasmids in the absence of tetracycline and was chosen to be used in the subsequent experiments.
The plasmids tet-cyclin E and tet-cyclin Dl were linearized by using ScaI, and the plasmid tet-cyclin Bi was linearized with SspI. Linearized DNA (10 jLg) was transfected together with 0.5 jig of Tk-hygromycin plasmid (linearized with HindlIl) into 60-mm-diameter plates of R12 cells. Tetracycline (1 jig/ml) was added to the culture medium. Clones were selected against 150 jLg of hygromycin (Calbiochem) per ml in the presence of tetracycline. Clones were screened for the ability to express the cyclin genes in the absence of tetracycline by immunoblot analysis with polyclonal antibodies specific for the different cyclins (see below). We found 3 inducing clones for cyclin E of 20 that were screened, 2 of 15 clones inducing cyclin DI, and 3 of 8 clones inducing cyclin B1. All the clones were maintained in medium containing 2 jig of tetracycline per ml, 150 jg of hygromycin per ml, and 350 jig of G418 per ml.
Western blot (immunoblot) analysis and Hi kinase assay. Cells were washed twice with phosphate-buffered saline (PBS) and lysed in lysis buffer containing 1% sodium deoxycholate, 1% Triton X-100, 50 mM Tris HCl (pH 7.5) 150 mM sodium chloride, 10 jig of leupeptin per ml, 10 jig of pepstatin per ml, 20 jig of aprotinin per ml, 10 mM sodium PPi, 50 mM sodium fluoride, and 0.5 mM sodium orthovanadate. Lysates were sonicated, microcentrifuged in the cold for 10 min, and stored at -80°C. Protein concentration was determined by using the Bio-Rad protein assay. Protein (50 to 100 jig) was run on a 7.5% acrylamide gel, blotted to an Immobilon membrane (Millipore), and reacted with the specified antibodies as previously described (7) . Polyclonal antibodies against cyclin E (7) were used to detect both the rat and the human proteins, and monoclonal antibodies against cyclin E (HE12, a gift of E. Lees and E. Harlow, Massachusetts General Hospital [MGH] Cancer Center) were used to detect the human protein alone. To detect cyclin DI protein, polyclonal antibodies against cyclin DI (6) were used, and to detect cyclin Bi protein, polyclonal antibodies prepared against the full-length cyclin BI protein (21) were used. When the same blot was reused with multiple antibodies, it was stripped between assays in 100 mM ,B-mercaptoethanol, 62.5 mM Tris HCl (pH 6.8), and 2% SDS for 30 min in 50°C.
For HI kinase assays, 100 jig of protein was used per immunoprecipitation with the polyclonal antisera described above or with monoclonal antibody HE172 (a gift of E. Lees and E. Harlow, MGH Cancer Center) to specifically precipitate human cyclin E protein. The immunoprecipitates were then washed once with lysis buffer; once with 1% sodium deoxycholate, 1% Triton X-100, and 150 mM Tris HCl (pH 7.5); once with 0.5 M lithium chloride, and once with 20 mM Tris HCI (pH 7.5) and 7.5 mM magnesium chloride. The washed immunoprecipitates were then incubated with 20 mM Tris HCI (pH 7.5), 7.5 mM magnesium chloride, 0.4 jig of histone Hi (Boehringer Mannheim) per ml, and 0.01 mCi of [-y_32P]ATP (4,500 Ci/mmol; ICN) for 30 min at 37°C. The products of the reaction were then run on an 11% polyacrylamide gel. The gel was stained, dried, and exposed to X-ray film. The histone bands were excised, and the amount of radioactivity was determined with a scintillation counter.
Cell cycle and growth rate analysis of asynchronous cells.
For cell cycle analysis, cells were seeded at 2.5 x 105 cells per 10-cm-diameter plate with or without 2 jig of tetracycline per ml. The medium was replaced 48 h later with fresh medium with or without tetracycline. After an additional 24 h, the cells were trypsinized, resuspended in medium containing 10% FCS, centrifuged, and resuspended in 1 ml of a solution containing 50 jig of propidium iodide (Sigma) per ml, 0.6% Nonidet P-40 (Calbiochem), and 0.1% sodium citrate. The stained cells were analyzed in a fluorescence-activated cell sorter (FACScan; Becton Dickinson) within Inducible expression and activity of human cyclins in rat cells. Clones E2, E19, D5, and B8 and a control clone were seeded in the presence or absence of tetracycline (tet) for 48 h and lysed as described in Materials and Methods. (A) Protein (50 jLg) was run on a 7.5% acrylamide gel and blotted as described in Materials and Methods. The same blot was reacted with cyclin E polyclonal and monoclonal antibodies (two upper panels), cyclin Dl polyclonal antibodies (third panel), and cyclin Bi polyclonal antibodies (fourth panel). The blot was stripped between assays as described in Materials and Methods. (B) Protein (100 ,ug) was used to analyze cyclin-associated histone Hi kinase activity as described in Materials and Methods. 105 cells per 60-mm-diameter plate with or without 2 jig of tetracycline per ml. Every 48 h, the medium was replaced with fresh medium with or without tetracycline. At the indicated times, cells were trypsinized, stained with trypan blue, and counted with a hemacytometer. At least 200 cells were counted for each sample. The experiment was performed three times with identical results.
Starvation-stimulation experiment. Cells were seeded at 2 x 105 cells per 60-mm-diameter plate in medium containing 10% FCS and 2 ,ug of tetracycline per ml. The medium was replaced 24 h later with medium containing 0.1% FCS and tetracycline. After 48 h, the medium was replaced with medium containing 0.1% FCS with or without tetracycline. The medium was again replaced 24 h later with medium containing 10% FCS with or without tetracycline, and cells were harvested for cell cycle analysis or for protein extraction at the indicated times.
Response to serum starvation. Cells were seeded at 10 x 105 cells per 10-cm-diameter plate in medium containing 10% FCS with or without 2 ,ug of tetracycline per ml. The medium was replaced 24 h later with medium containing 0.1% FCS with or without tetracycline. Samples were taken for cell cycle analysis or for protein extraction at the indicated times.
RESULTS
Transfectant cell lines using the tTA system. Gossen and Bujard (9) have described an artificial transcriptional regulatory system which uses the bacterial tetracycline resistance operator/repressor. A chimeric protein composed of the tetracycline repressor fused to the activation domain of the herpesvirus transcriptional activator, VP16, serves as the transactivator (tTA). The target of this transcription factor is a synthetic promoter composed of tandem repeats of the tetracycline operator and a minimal eukaryotic promoter. The presence of tetracycline prevents binding of the transactivator to the promoter. Removal of tetracycline induces transcription of a gene under the control of this promoter. A plasmid expressing the tTA transactivator was transfected into the rat embryo fibroblast cell line Rat-1, and stable transfectant clones were identified by screening with a transient-expression assay (see Materials and Methods). One of these Rat-1 derivatives (R12) was transfected with expression clones constructed by placing cyclin cDNAs downstream of the synthetic tetO promoter and by using a cotransfection marker (hygromycin resistance). Hygromycin-resistant cell lines were screened for conditional expression of cyclins Bi, Dl, and E. Cell lines transfected with just the expression vector were isolated as controls. Clones Effects of cyclin expression on cell cycle distribution and growth rate of asynchronous cells. (A) Clones E2, E19, D5, and B8 and a control clone were seeded in the presence or absence of tetracycline (tet) for 72 h and analyzed by flow cytometry as described in Materials and Methods. Five plates of each cell line were used for five independent analyses, and the bar graph shows the standard error calculated for the data. (B) The growth rates of clones E2 and D5 in the presence and absence of tetracycline were measured as described in Materials and Methods. Trypan blue staining showed that there was not any detectable cell death under these conditions. displaying highly regulated expression were obtained for each of the cyclins (Fig. 1A ). It should be noted, however, that all clones exhibited a low basal level of cyclin expression in the presence of tetracycline, which was detectable in most of the experiments performed (Fig. 1A ).
The immunoblots in Fig. 1 show the levels of cyclin E, cyclin Dl, and cyclin Bi expression attained in the presence and absence of tetracycline in the clones that were selected for this study. Clone D5 expresses human cyclin DI which comigrates with the endogenous rat cyclin Dl (Fig. IA) . Clones E2 and E19 express two forms of the human cyclin E protein, with molecular masses of 44 and 39 kDa. Neither of these clones (or any of the other clones that we have screened) expresses any human protein that comigrates with the rat cyclin E (51 kDa) as shown by using human-specific cyclin E monoclonal antibodies ( Fig. 1A ). Although Rat-I cells do not express the more rapidly migrating forms of cyclin E, most human cell lines and strains that we have investigated express all three forms, of which the 51-kDa protein is the most abundant. We are currently investigating the possibility that the cDNA employed in these experiments corresponds to one of two alternatively spliced forms of cyclin E mRNA and that the 51-kDa protein is encoded by another mRNA. Two differentially spliced forms were recently described for Drosophila cyclin E (38) . At this point, we do not know the functional significance of the different cyclin E species, if any. Clone B8 expresses a protein that comigrates with the rat cyclin Bi, as well as an additional, slightly more rapidly migrating protein that is likely to be a degradation product (Fig. 1A) .
Inducing clones were also analyzed for cyclin-associated protein kinase activity. In an asynchronous culture, the cyclin Bl-expressing clone showed a 2.5-fold elevation in in vitro cyclin Bi-associated histone Hi kinase activity, indicating that active cyclin was being expressed (Fig. 1B) . Likewise, cyclin E-expressing clones showed elevation in cyclin E-associated histone Hi kinase activity (Fig. 1B ). This could be demonstrated by using polyclonal antibodies that recognize both the endogenous rat cyclin E and the exogenous human cyclin E, in which the aggregate cyclin E-associated activity was increased approximately fourfold in the absence of tetracycline, or by using a human-specific monoclonal antibody, in which activity could only be detected in the absence of tetracycline ( Fig. 1B ). We could not measure changes in cyclin Dl-associated activity, since no kinase assay has yet been developed for type D cyclins in mammalian cells.
Cell cycle effects on asynchronous cells. Cell lines expressing cyclins B1, D1, and E and the vector alone were grown continuously in the presence of 2 [Lg of tetracycline per ml. For parallel cultures, growth was continued in either the presence or the absence of tetracycline for 72 h, and cell cycle distribution was measured with a fluorescence-activated cell sorter (FACS). Five different plates with tetracycline and five different plates without tetracycline were analyzed in these experiments. Flow cytometric analysis indicated that chronic constitutive synthesis of cyclin E in two independent cell lines (E2 and E19) led to a diminution in the proportion of cells with unreplicated nuclear DNA by 25% and a relative increase in the fraction of cells with replicating and replicated DNA ( Fig.  2A ). Two cell lines expressing cyclin Dl showed a qualitatively similar but less pronounced cell cycle redistribution. Clone D5 exhibited a decrease of the G1 population by 15% ( Fig. 2A) , while clone D3 which expressed cyclin Dl at similar levels (data not shown) showed a decrease of the GI population by 10% ( Table 1) . A cell line expressing cyclin Bi (clone B8) and " The length of G, in asynchronous cells was calculated from the percentage of cells in G, (determined in the experiment described in the legend to Fig. 2A ) and the length of the cell cycle calculated from the growth curves in Fig. 2B (14 h) .
The decrease in the length of G, in cycling cells (G, to S) is the difference between the length of G, in the absence and presence of tetracycline. The standard deviations are the standard deviations corresponding to the distribution of differences between the length of G, in the absence and presence of tetracycline and were calculated from the standard deviations determined for the experiment described in the legend to Fig. 2A . " To calculate the decrease in the length of G, in cells emerging from quiescence (G,JG, to S), the time point corresponding to 30% of the cells in S phase was calculated from the graphs in Fig. 4B . 30% was chosen because the maximum percentage in S phase in these experiments was 60%k; thus, this point represents the 50%/c maximum of cells in S phase. The difference (in hours) between the time at which 30% of the cells were in S phase with or without tetracycline was then calculated. The decrease of length of G(VG, to S was calculated from four biological experiments for clone D5 and from three biological experiments for clones D3, E2, and E19. The calculated standard deviations from these experiments are shown.
' The t score for the difference between columns 2 and 3 was calculated on the basis of Student's t distribution. ot was calculated by using the table of the t distribution, where v = 7 degrees of freedom for clone D5 and 6 degrees of freedom for clones D3, E2, and E19. Levels of confidence of -99% are considered highly significant. Levels of confidence below 95% are considered not significant. several controls expressing no exogenous cyclin showed no apparent cell cycle redistribution in the absence of tetracycline ( Fig. 2A ). Although the changes in the proportions of cells in G1 as a result of cyclin expression were small, they were highly significant. Statistical analysis with Student's t distribution revealed that the percentage of cells in G1 without cyclin induction is different from the percentage of cells in G, with cyclin induction, with a level of confidence that is higher than 99%, for all four clones analyzed (i.e., D3, D5, E2, and E19).
We then measured the growth rates of all cell lines in the presence or absence of tetracycline. As shown in Fig. 2B , the cell number with or without tetracycline was followed for 5 days (seven to eight cell cycles) for clones E2 and D5, with no difference detectable. The same results were obtained for clone E19 (not shown). We calculated that if the 15% reduction in the proportion of G1 cells observed with clone D5 ( Fig.  2A ) were due to an uncompensated reduction in the length of GI, the cell cycle would be 1 h shorter, yielding a 50% increase in cell number (relative to noninduced cells) after 5 days. Similarly, for clones E2 and E19, a twofold increase could be anticipated. Such differences would have been readily detected. We therefore conclude that constitutive ectopic expression of cyclins E and Dl shortens the G1 interval by advancing S phase but increases the length of S phase and G2 in a compensatory fashion. Thus, constitutive overexpression of cyclin E or DI has a significant capacity to advance the G,/S phase transition.
Emergence from quiescence. A common method of synchronizing fibroblasts is to deprive them of essential growth factors, which causes them to enter into a quiescent state termed Go.
Upon restoration of growth factors, cells traverse the cell cycle in partial synchrony. The time required to enter into S phase after growth factor stimulation is the aggregate of the time required to emerge from quiescence (Go) and that required to traverse G1. Therefore, cells capable of conditional cyclin expression as well as controls that had been maintained in 0.1% FCS for 48 h were induced for cyclin expression by removal of tetracycline and maintained in 0.1% FCS for an additional 24 h. After stimulation with 10% FCS in the presence or absence of tetracycline, cells were monitored for entry into S phase by flow cytometric analysis. Removal of tetracycline caused a definitive acceleration of entry into S phase for clones E2, E19, D3, and D5 ( Fig. 3 and Table 1 ), while it had no effect on entry into S phase for clone B8 and a number of different control clones (Fig. 3B ). Figure 3A Although the actual numbers vary between experiments, this phenomenon was highly reproducible. This observation suggests that whereas cells chronically expressing cyclins DI and E have a cell cycle time comparable to that of controls (Fig. 2B) , the cell cycle time is shorter for cyclin-expressing clones on the first cycle after emergence from quiescence (see Discussion). Figure 3B also shows that the different clones, under noninducing conditions, entered S phase at different rates. Analysis of a large number of control clones by this experimental procedure has shown that the time of entrance into S phase varies between the different control clones by up to 4 h (data now shown). We therefore conclude that kinetic variations between individual clones in entrance to S phase under noninducing conditions are likely to be due to clonal variation. This does not affect any of our conclusions, which are solely based on comparing kinetics between induced and noninduced cells of the same clone.
In contrast to the results obtained for asynchronous cultures, cyclin Dl appeared to provide a greater advancement than did cyclin E for cells emerging from quiescence (Fig. 3) . Table I summarizes the decrease in the length of G, upon cyclin induction in asynchronous cells compared with that in cells emerging from quiescence. The decrease in the length of G, in cells emerging from quiescence was very similar to that observed in asynchronous populations, for the two cyclin E-expressing clones. However, for the two cyclin DI-expressing clones, the decrease in the length of G, in cells emerging from quiescence was five to seven times greater than that seen in asynchronous populations. Statistical analysis revealed that the decrease in the length of G1 in cells emerging from quiescence was different from that seen in asynchronous populations at a 99% or greater confidence level for the two cyclin Dlexpressing clones but was not significantly different for the two cyclin E-expressing clones ( Table 1 ). The possible significance of these results will be discussed below.
Expression of cyclins and cyclin-associated histone kinase activity were analyzed at 3.5 and 18 h after serum stimulation under both inducing and noninducing conditions (Fig. 4) . The protein levels of cyclins E and DI were maximally induced by 3.5 h after serum stimulation (Fig. 4A) . The cyclin E-associated kinase activity was measured by using polyclonal antibodies which recognize both exogenous and endogenous proteins. It is shown in Fig. 4A 3 . Effects of cyclin expression on the kinetics of cell cycle progression after serum starvation/stimulation. Clones E2, D5, and B8 and a control clone were starved in 0.1% FCS before the cyclin cDNAs were induced by removal of tetracycline (tet). Serum stimulation was 24 h later as described in Materials and Methods. Cultures harvested at the indicated times after release from the block were analyzed for DNA content by flow cytometry. (A) The original DNA content data are shown for clone D5 (left column) and clone E2 (right column). (B) The percentage of cells in S phase for each clone at various times after serum stimulation was calculated from flow cytometric measurements of DNA content. h after serum stimulation, although a further increase is as being due to the activity of the endogenous cyclin E, since detected at 13 h. The same samples, when assayed with the cyclin-expressing cells were beginning to enter S phase monoclonal antibodies (that recognize only the exogenous during this interval (Fig. 3B) . Nevertheless, the level of the protein), seem to vary little, if at all (not shown). We therefore cyclin E-associated kinase activity at 3.5 h after serum stimuinterpret the elevation in kinase activity between 3.5 and 13 h lation was very similar to the level seen in G1/S control cells cyclin Dl cyclin Bi E2 / / I activity. We conclude from Fig. 5 that even though high levels of cyclin synthesis and, for cyclin E, kinase activity could be maintained under serum starvation conditions, proliferation was not maintained. In the case of clone D5, proliferation had not ceased completely until 72 h after transfer to 0.1% serum. At this time there was a reduction in the level of ectopic cyclin DI expression (data not shown). However, since the kinetics of arrest clearly preceded the kinetics of cyclin DI reduction, we conclude that attainment of quiescence occurs even in the presence of high levels of cyclin DI. Fig. 3 . At 3.5, 13, and 18 h after serum stimulation, cell extracts were prepared as described in Materials and Methods. The protein levels of the different cyclins (A) and the associated kinase activity (B) were determined as described in the legend to Fig. 1. (expressing only endogenous cyclin E) at 18 h ( Fig. 3B and 4B) . The kinase activity associated with cyclin DI cannot be measured in vitro; however, we have evidence that cyclin DI is active in vivo 3.5 h after stimulation (37a). Yet, entry of cells into S phase was not observed until 10 h after serum stimulation for clone D5 and 13 h after serum stimulation for clone E2 (Fig. 3B) . The possible significance of these results will be discussed below. Figure 4 also shows that the cyclin Bi protein and associated kinase activity were well induced in clone B8 3.5 h after serum stimulation.
Responses to serum starvation. As described above, when the level of serum in growth medium is lowered to 0.1%, nontransformed fibroblasts cease proliferation and enter into a quiescent state. One possible explanation for the serum requirement is that serum stimulation regulates biosynthesis of G1 cyclins, required for movement through or exit from G To test this hypothesis, we transferred cell lines constitutively expressing cyclins DI and E to medium containing 0.1% FCS. None of these cell lines was capable of continued proliferation under these conditions (Fig. 5A) , although clones expressing cyclins DI and E took longer to accumulate in G(/G1. Since the kinetics of accumulation in G(/G1 (i.e., the slope of the curves in Fig. SA) are not affected by cyclin expression, this delay is likely to be due to the greater percentage of cells in S + G2 + M in the prestarved populations. In order to confirm that biosynthesis of ectopic cyclins was occurring under serum starvation conditions, lysates were prepared after 48 h in 0.1% FCS and assayed for cyclin DI and E protein ( Fig. SB) and cyclin E-associated histone kinase activity (Fig. SC) . Figure SB shows that under low-serum conditions, cyclin E and DI proteins were induced to levels comparable to those seen in asynchronous populations. Figure 5C shows that the human cyclin E-associated kinase activity was also induced to a level similar to that seen in asynchronous populations, excluding the possibility that starved cells are incapable of maintaining this DISCUSSION Cyclins DI and E are rate-limiting GI cyclins. Cyclins C, DI, and E were identified in a search for mammalian cDNAs that could rescue an S. cerevisiae strain lacking G, cyclins (14, 17, 48) . Surprisingly, most mammalian cyclins (including cyclins A, Bi, and B2) were able to rescue this yeast strain, leaving the function of the novel cyclins in doubt (17) . Subsequent studies showed that cyclin E mRNA, protein, and associated histone HI kinase activity accumulated periodically during the cell cycle, with a peak near the G1/S transition, suggesting that cyclin E might play a role in triggering this transition (5, 7, 15, 17, 43) . The first direct evidence for a rate-limiting GI function for cyclin E came from a study that was published while this work was in progress and which showed that cells infected with a constitutive cyclin E-expressing retrovirus have a shorter GI phase (28) . A similar role has been proposed for cyclin DI, although its expression is triggered rapidly upon growth factor stimulation and remains constant thereafter during the cell cycle (20, 46) . A recent study has shown that constitutive overexpression of cyclin DI, as with cyclin E, can cause premature entrance to S phase, indicating a rate-limiting role for cyclin DI in the G,/S transition (35) . Cyclin DI was also recently shown to be essential for the GI/S transition, since microinjection of antibodies against cyclin DI during Gl prevented entrance to S phase (2, 35) .
In this study we showed that induced expression of cyclin DI and E resulted in accelerated entrance to S phase, which indicates that these cyclins are rate-limiting positive regulators of the G,-to-S phase transition. These results basically confirm the observations of Ohtsubo and Roberts (28) for cyclin E and those of Quelle et al. (35) for cyclin DI. However, this study also contains several novel observations (see below) and is different in experimental design. In contrast to the previous studies which were based on constitutive expression of cyclins, this study utilizes the tTA conditional expression system. In fact, it is the first demonstration of this system in the context of addressing important biological questions and clearly underscores its efficacy. The use of the inducible system had certain advantages as well as a number of disadvantages in comparison with use of the constitutive expression systems. First, it allowed us to avoid potential artifacts associated with chronic cyclin expression during weeks of selection. Second, it allowed us to compare the behavior of the same genetically homogeneous clones under inducing and noninducing conditions, factoring out clonal variation and allowing quantitative assessments of cell cycle effects conferred by particular levels of cyclin expression. Its disadvantage, however, is the limited number of clones analyzed. Even though both of the cyclin E-expressing clones and both of the cyclin DI-expressing clones, respectively, behaved similarly, this does not constitute a statistical sample population of each type. The previous studies (28, 35) , on the other hand, used pools composed of large numbers of different clones, thus avoiding the limitation of small samples. However, since the populations were composed of clones expressing Effects of cyclin induction on the response to serum starvation. Clones E2, E19, and D5 and a control clone were starved in 0.1% FCS after induction of the cyclin as described in Materials and Methods. (A) The percentage of cells in S phase for each clone at various times after serum starvation were calculated from flow cytometric measurements of DNA content. (B) Cells were extracted 48 h after starvation as described in Materials and Methods. The protein levels of the different cyclins were determined as described in the legend to Fig. 1. (C) The cyclin E-associated kinase activity was determined by using the monoclonal antibody HE172, which specifically recognizes human cyclin E. tet, tetracycline. exogenous cyclin at different levels (some of them perhaps not expressing cyclin at all), one cannot relate such expression levels easily to the degree of cell cycle advance. In addition, since the expression was not conditional, subpopulations exhibiting particular behaviors may have been selected against, providing a biased average.
The observation that virtually all human cyclins can substitute for S. cerevisiae G1 cyclins in a G1 cyclin-deficient strain (17) raised the possibility that overexpression of any cyclin might be sufficient to advance S phase. However, our experiments showed that a clone expressing an active human cyclin Bi showed no cell cycle aberrations relative to control clones ( Fig. 1 and 2A) . The fact that no advance of S phase was observed for cycling and synchronized populations constitutively expressing active cyclin Bi (Fig. 1, 2A, 3B, and 4) indicates that not every cyclin when expressed can have an impact on the length of the G1 interval. This is a critical control for inferring a G1-specific function for cyclins Dl and E and was not included in the previous studies.
This study is the first to compare the effects of overexpression of cyclins E and Dl in parallel in the same cell system. We were therefore able to draw qualitative and quantitative conclusions that suggest differential function of these cyclins (see below).
Cyclins Dl and E shorten G1 only to a limited extent. In yeasts, when G, cyclins are transcribed constitutively or overexpressed, the G1 phase is shortened, and under extreme circumstances, G1 is virtually dispensable, with cells apparently entering S phase directly from mitosis (36) . We show that in mammalian cells, unlike in yeasts, the capacity of G1 cyclins to advance S phase is limited. In cycling cells, only a 25% decrease in the length of G, was observed upon cyclin E overexpression and only a 10 to 15% decrease in the length of G1 was observed upon cyclin Dl overexpression ( Fig. 2A ; Table 1 ). Direct measurements of the length of G1 in populations synchronized by serum starvation/stimulation ( Fig. 3) show that G1 can be shortened by cyclin E or Dl induction but cannot be eliminated. This is despite the fact that the protein (37a) . Similar results were reported by Ohtsubo and Roberts (28) for cyclin E and by Quelle et al. (35) for cyclin Dl. We therefore conclude that in contrast to yeast cells, in mammalian cells only a limited window of the G1 interval is sensitive to constitutive expression of G1 cyclins. Likely explanations for this are that the critical substrates for the relevant kinases are not available during most of G, or that the targeted regulatory network is not operative until certain G1 landmarks have been traversed.
In mammalian cells, passage through a late-G, restriction point (R) defines the time at which cells no longer require growth factors to enter S phase, which occurs approximately 2 h later (30) . An accumulation of an unstable protein(s) is required to pass the R point, and it has been postulated that such proteins might be G1 cyclins, which would then regulate Cdks to drive cell cycle progression in a rate-limiting manner (5) . It has been assumed, although not proven, that accumulation of this unstable protein would be rate limiting for execution of the R point. If indeed activation of a particular Cdk is equivalent to execution of the R point, then one should expect that activation of this kinase by a rate-limiting cyclin would precede entrance to S phase by approximately 2 h. The long delays between cyclin E and Dl induction and the time of entrance into S phase in our experiments suggest that activation of the cyclin E-or Di-associated kinase is not equivalent to execution of the R point, on the basis of the simple model outlined above. However, it is possible that the R point can be executed only during a defined window late in the G1 interval, rendering earlier activation of Cdks inconsequential.
Adjustment of the cell cycle to chronic cyclin E and DI overexpression. We have observed that even though cycling cells experiencing constitutive overexpression of cyclins Dl and E had a lower percentage of cells in the G1 phase, their cell cycle transit times were unaltered (Fig. 2 ). There are two alternative explanations for this observation. The first is that the primary effect of cyclin E and DI overexpression is to shorten G1 and, as a consequence, S and G2 are longer (possibly because acceleration of G1 produces smaller S phase and G2 cells that perform essential functions inefficiently). The second explanation is that the primary effect of cyclin expression is to delay S and G2, thus shortening the subsequent G1 (possibly as a consequence of the increased time available for cell growth in the previous cell cycle). Using serum starvation/ stimulation synchrony, we have shown that the first G1 after cyclin Dl and E induction is shorter relative to that of noninduced cells (Fig. 3) . These observations strongly suggest that the primary effect of cyclin Dl and E overexpression was to shorten GI. Although we have not analyzed cell size in detail, it has been reported that cells constitutively overexpressing cyclin E and cyclin Dl attain a reduced cell size (28, 35) , which is consistent with the hypothesis that the delay in S and G2 is a result of smaller cell size. Interestingly, in cells displaying an accelerated entry into S phase out of quiescence due to cyclin overexpression, we did not observe a compensatory deceleration of S phase and G2 during the first cell cycle (Fig. 3A ), suggesting that this adjustment takes some time to establish and is perhaps correlated with an eventual diminution of cell size.
A previous study showed no change in cell cycle length for fibroblasts constitutively overexpressing cyclin E (28) , in agreement to our finding. However, cells constitutively overexpressing cyclin Dl were reported to have a shorter cell cycle time relative to those of control cells (35) . This discrepancy might result from differences in the cell lines used in the two studies, differences in the levels of cyclin overexpression, or other differences in experimental design.
Cyclin Dl versus cyclin E. Constitutive expression of either cyclin Dl or cyclin E confers advance of entry into S phase in asynchronously dividing cells ( Fig. 2A) or in cells emerging out of quiescence (Fig. 3 ). However, whereas expression of cyclin E had a similar impact on asynchronous dividing cultures and on cells emerging from quiescence, expression of cyclin DI caused a significantly more dramatic decrease in the length of G, in cells emerging from quiescence than in cycling cells (Table 1 ). Even though these results have been shown to be statistically significant for the four clones studied here (i.e., D5, D3, E2, and E19 [ Table 1 ]), we cannot rule out the possibilities that these clones are, by chance, atypical and that examination of additional clones would not support differential behavior for cyclins E and Dl. Assuming, however, that our results can be generalized, there are two plausible explanations for the differential behavior of these cyclins. The first derives from the difference in patterns of synthesis characteristic of cyclins Dl and E through the cell cycle (42) . Whereas once cells are cycling cyclin Dl appears to be maintained constitutively at the protein level, cyclin E has been shown to be periodically expressed each cell cycle. Therefore, constitutive ectopic expression of cyclin E would be expected to have a greater impact than that of cyclin Dl on actively cycling cells, especially if the latter were already maintained near functionally saturating levels in nontransfected cells. However, under conditions in which levels of cyclin Dl would need to be restored, such as after serum starvation, cells ectopically expressing high levels would be expected to experience an accelerated entry into S phase. An alternative explanation for these observations is that cyclin Dl is required at two different regulation points, one early in Go/Gl and one later in Gl. This two-function model is consistent with the observation that cyclin Dl synthesis is an early response to growth factor stimulation in fibroblasts and macrophages (20, 46) and with the finding that injection of anti-cyclin Dl antibodies or antisense plasmid, as late as 12 h after serum stimulation, can block entrance to S phase (2, 35 Overexpression or deregulated expression. An inherent potential problem in ectopic expression studies is the difficulty in distinguishing between effects of deregulated expression and effects of overexpression per se. In this study, as well as the previous ones describing effects of cyclin overexpression (28, 35) , it could be argued that these cyclins, as a consequence of abnormal expression levels, assume the functions of other cyclins and the observed phenotype has little relevance to the role of the endogenous cyclin under study. It is difficult to estimate the levels of exogenous cyclin expression in this study, since we expressed human cDNAs in rat cells, and it is possible that the polyclonal antibodies used, which were made against human proteins, have higher reactivities with the exogenous human cyclins than with their endogenous rat homologs. Thus, even though it appears from the Western blots in this study (Fig. 1A, 4A , and 5B) that the exogenous protein levels are much higher than the endogenous ones, we cannot draw rigorous quantitative conclusions concerning relative expression levels. However, the cyclin Bi control used in this study provides a counterargument on this issue, since cyclin Bi expression had no effect on the G1/S transition ( Fig. 2A and  3B) , even though the cyclin Bi-associated kinase was shown to be induced in G1 (Fig. 4B ) and the ratio between endogenous and exogenous proteins was similar to that observed for cyclin Dl (Fig. 1A and 4A ).
Response to serum starvation. Cells that are deprived of growth factors cease proliferation and enter into a quiescent state. It has been shown that the level of cyclin Dl and cyclin E in quiescent cells is decreased relative to that in cycling cells (3, 5, 6, 20, 43, 46) . In principle, this reduction in cyclin level could be responsible for cell cycle arrest or could be a result of it. To discriminate between these two possibilities, we transferred cell lines constitutively expressing cyclin DI or E to medium containing 0.1% FCS. We showed that cyclins E and Dl and cyclin E-associated kinase activity were induced under starvation conditions ( Fig. SB and C) , which is a novel and unexpected observation. Despite this fact, the cyclin-expressing cells, although they reached G,/Gl arrest about 24 h later than controls, were not capable of continued proliferation (Fig. 5A ). Similar results were recently reported for constitutive expression of cyclin E (28) and cyclin Dl (35) . However, these studies did not follow the kinetics of cell cycle arrest after serum starvation, nor did they confirm the expression of the exogenous cyclins under these conditions. On the basis of these results, it can be concluded that the requirement of fibroblasts for growth factors cannot simply be explained as a signal for the biosynthesis of a particular G1 cyclin. These experiments, however, do not rule out the possibility that the growth factor requirement reflects a dependency for biosynthesis of more than one cyclin.
